Orthofix Medical (OFIX) Depreciation & Amortization (CF) (2010 - 2025)

Orthofix Medical (OFIX) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $34.4 million in Q1 2025.

• Quarterly Depreciation & Amortization (CF) rose 131.67% year-over-year to $34.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $34.4 million (down 42.67% YoY) and the FY2025 annual result came in at $47.3 million, down 21.25% from the prior year.
• Depreciation & Amortization (CF) grew to $34.4 million in Q1 2025, from $16.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $34.4 million in Q1 2025 to a low of $6.5 million in Q2 2022.
• A 5-year average of $12.1 million and a median of $12.7 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) retreated 20.81% — and 2025, when it soared 131.67%.
• Tracing OFIX's Depreciation & Amortization (CF) over 5 years: stood at $7.4 million in 2021, then dropped by 0.34% to $7.4 million in 2022, then soared by 88.24% to $14.0 million in 2023, then increased by 14.5% to $16.0 million in 2024, then surged by 115.27% to $34.4 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $34.4 million (Q1 2025), $16.0 million (Q4 2024), and $15.2 million (Q3 2024), per Business Quant data.